English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

delta 9 tetrahydrocannabinol/cannabis

The link is saved to the clipboard
10 results

Method for increasing cannabinol content in a lipid-based extract of cannabis

Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION This invention relates to ways of extracting and concentrating cannabinoids from plant substrates including hemp, and particularly ways of modifying ratios of various cannabinoids including trans-.DELTA.9-tetrahydrocannabinol (THC), Cannabinol (CBN) and Cannabidiol

Mixtures of cannabinoid compounds, and production and use thereof

Only registered users can translate articles
Log In/Sign up
CROSS REFERENCE TO RELATED APPLICATIONS This application is a national stage application (under 35 U.S.C. .sctn.371) of PCT/EP2014/063872, filed Jun. 30, 2014, which claims benefit of European Application No. 13182788.3, filed Sep. 3, 2013, the entire contents of which is fully incorporated herein

Orally consumable cannabinoid composition including lecithin

Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION The present invention pertains to a pharmaceutical composition comprising .DELTA.9 Tetrahydrocannabinol (THC), Cannabidiol (CBD), at least one small molecule selected from Citric Acid, Ascorbic Acid, Citrus Essential Oil(s), Lecithin, one or more sugar(s), Resveratrol, and

Pharmaceutical composition comprising Cannabinoids

Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION The present invention pertains to a pharmaceutical composition comprising .DELTA.9 Tetrahydrocannabinol (THC), Cannabidiol (CBD), and at least one small molecule selected from Citric Acid, Ascorbic Acid, Citrus Essential Oil(s), Lecithin, one or more sugar(s), Resvertrol, and

Cannabinoid composition including a cytochrome p450 enzyme inhibitor

Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION The present invention pertains to a pharmaceutical composition comprising .DELTA.9 Tetrahydrocannabinol-(THC), Cannabidiol (CBD), and a cytochrome p450 enzyme inhibitor. BACKGROUND OF THE INVENTION Cannabinoids are a group of chemicals from Cannabis Sativa or Cannabis indica

Controlled Cannabis decarboxylation

Only registered users can translate articles
Log In/Sign up
FEDERAL SUPPORT STATEMENT Not Applicable SEQUENCE LISTING Not Applicable BACKGROUND OF THE INVENTION Raw cannabis contains tetrahydrocannabinol carboxylic acid (THC-COOH); this substance is also referred to as THC acid, .DELTA.9-THC acid, THCA-A, or THCA. The article that appears in the Journal of

Encapsulated cannabinoid formulations for transdermal delivery

Only registered users can translate articles
Log In/Sign up
This application includes material that is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent disclosure, as it appears in the Patent and Trademark Office files or records, but otherwise reserves all copyright rights

Encapsulated cannabinoid formulations for oral delivery

Only registered users can translate articles
Log In/Sign up
This application includes material that is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent disclosure, as it appears in the Patent and Trademark Office files or records, but otherwise reserves all copyright rights

Cannabinoid derivatives, methods of making, and use thereof

Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION The present invention relates generally to cannabinoid derivatives of delta-8-tetrahydrocannabinol (.DELTA..sup.8-THC), delta-9-tetrahydrocannabinol (.DELTA..sup.9-THC), and delta-6a-10a-tetrahydrocannabinol (.DELTA..sup.6a-10a-THC) that are active as either agonists or

Method for purifying cannabinoid compounds

Only registered users can translate articles
Log In/Sign up
CROSS-REFERENCE TO RELATED APPLICATIONS This application is a national stage application (under 35 U.S.C. .sctn. 371) of PCT/EP2016/060905, filed May 13, 2016, which is incorporated herein by reference in its entirety. The present invention relates to methods for purifying one or two cannabinoid
Join our facebook page

The most complete medicinal herbs database backed by science

  • Works in 55 languages
  • Herbal cures backed by science
  • Herbs recognition by image
  • Interactive GPS map - tag herbs on location (coming soon)
  • Read scientific publications related to your search
  • Search medicinal herbs by their effects
  • Organize your interests and stay up do date with the news research, clinical trials and patents

Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research

Google Play badgeApp Store badge